Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Arcturus Therapeutics : Citigroup Adjusts Price Target on Arcturus Therapeutics Holdings to $114 From $118, Keeps Buy Rating

08/25/2021 | 07:51am EST


ę MT Newswires 2021
All news about ARCTURUS THERAPEUTICS HOLDINGS INC.
11/22Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
BU
11/18Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
11/16ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for..
AQ
11/16Cantor Fitzgerald Adjusts Price Target on Arcturus Therapeutics Holdings to $93 From $8..
MT
11/09Barclays Adjusts Price Target on Arcturus Therapeutics to $31 From $46, Keeps Underweig..
MT
11/09ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial ..
AQ
11/08Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre..
PU
11/08ARCTURUS THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/08Arcturus Therapeutics Q3 Loss Widens -- Stock Down 1% After-Hours
MT
11/08Arcturus Therapeutics Holdings Inc. Reports Earnings Results for the Third Quarter Ende..
CI
More news
Analyst Recommendations on ARCTURUS THERAPEUTICS HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 23,8 M - -
Net income 2021 -206 M - -
Net cash 2021 306 M - -
P/E ratio 2021 -5,13x
Yield 2021 -
Capitalization 1 052 M 1 052 M -
EV / Sales 2021 31,3x
EV / Sales 2022 2,91x
Nbr of Employees 118
Free-Float 86,0%
Chart ARCTURUS THERAPEUTICS HOLDINGS INC.
Duration : Period :
Arcturus Therapeutics Holdings Inc. Technical Analysis Chart | ARCT | US03969T1097 | MarketScreener
Technical analysis trends ARCTURUS THERAPEUTICS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 39,89 $
Average target price 85,45 $
Spread / Average Target 114%
EPS Revisions
Managers and Directors
Joseph E. Payne President, Chief Executive Officer & Director
Andrew H. Sassine Chief Financial Officer & Director
Peter C. Farrell Chairman
Padmanabh Chivukula Secretary, Chief Operating & Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCTURUS THERAPEUTICS HOLDINGS INC.-8.05%1 052
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431